ADCs, when combined with colony-stimulating factors (G-CSF/GM-CSF), have a comparable safety signal (IC025, 2.58 vs. 2.63) for sepsis than ADCs’ monotherapy (Table 5). The gene discussed is CSF2; the disease is Sepsis.